PMID: 11920757Mar 29, 2002Paper

Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats

Journal of Pharmaceutical Sciences
Shigeki TamuraShinji Yamashita

Abstract

The objective of this study is to investigate the role of P-glycoprotein (P-gp), a membrane efflux pump associated with multidrug resistance (MDR) and a known substrate for tacrolimus, in determining the regional intestinal permeability of tacrolimus in rats. Thus, isolated segments of rat jejunum, ileum, or colon were perfused with tacrolimus solutions containing polyethoxylated hydrogenated castor oil 60 surfactant, and with or without verapamil, a P-gp substrate used to reverse the MDR phenotype. The results indicated that the intrinsic permeability of tacrolimus in the jejunum, calculated on the basis of the concentration of non-micellized free tacrolimus, was quite high ( approximately 1.4 x 10(-4) cm/s). The apparent permeability (P(app)) in the jejunum was unaffected by the presence of verapamil; however, the P(app) in the ileum and the colon increased significantly in the presence of verapamil and were similar to the values observed in the jejunum. The results suggest that systemic absorption of tacrolimus from the gastrointestinal tract could be significantly affected by P-gp efflux mechanisms. It is also possible that differences in P-gp function at various intestinal sites in a subject or at a given intestinal site i...Continue Reading

References

Mar 25, 1975·Biochimica Et Biophysica Acta·A Helenius, K Simons
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·M NaitoT Tsuruo
Sep 1, 1990·Annals of Surgery·S TodoR Shapiro
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A T FojoI Pastan
Oct 28, 1989·Lancet·T E StarzlA Jain
Jan 1, 1982·Journal of Pharmaceutical Sciences·G E AmidonN F Ho
Mar 1, 1995·Clinical Pharmacology and Therapeutics·W J JuskoQ A Mekki
Sep 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·H K KroemerM Eichelbaum
Feb 15, 1993·Biochemical and Biophysical Research Communications·P S BurtonN F Ho
Dec 1, 1995·Clinical Pharmacokinetics·R VenkataramananT Starzl
Jul 1, 1997·Clinical Pharmacology and Therapeutics·L C FlorenM F Hebert
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher

❮ Previous
Next ❯

Citations

Jul 10, 2012·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Zahra Nasiri-ToosiSima Sadrai
Apr 13, 2013·International Journal of Pharmaceutical Investigation·Pranav PatelTejal Mehta
Jan 25, 2014·International Journal of Pharmaceutics·Masayuki YamanakaShigeru Itai
Jul 9, 2013·Journal of Pharmacological and Toxicological Methods·Zhiqiang LuoLi Wei
Sep 18, 2008·Drug Development and Industrial Pharmacy·Alan B WattsJay I Peters
Feb 3, 2015·Expert Opinion on Drug Delivery·Saba KhanJaved Ali
Nov 4, 2008·Drug Development and Industrial Pharmacy·Vivek Baban BorhadeDarshana Deepak Hegde
Feb 24, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Changkyu LeeYu Seok Youn
Aug 3, 2006·Journal of Pharmaceutical Sciences·Kasiram KatneniChristopher J H Porter
Jan 10, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Takayuki YoshidaKazuhiro Sako
May 15, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Marietta von Suesskind-SchwendiKarla Lehle
Mar 31, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Pallavi V Pople, Kamalinder K Singh
Jun 29, 2010·International Journal of Pharmaceutics·Jung Hyun JoeHan-Gon Choi
Sep 30, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Taher NassarSimon Benita
Jan 30, 2004·Journal of Clinical Pharmacology·HongXia ZhengGilbert J Burckart
Apr 16, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·HongXia ZhengGilbert J Burckart
Sep 23, 2010·Neurourology and Urodynamics·Yao-Chi ChuangMichael B Chancellor
Jan 1, 2014·Lower Urinary Tract Symptoms·Bharathi Raja RajaganapathyMichael B Chancellor
Feb 7, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hiroshi SaitohBruce J Aungst
Dec 6, 2012·The Journal of Dermatological Treatment·Raj Kumar Thapa, Bong Kyu Yoo
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H Lennernäs
Feb 1, 2005·Drug Metabolism and Pharmacokinetics·Takahiro IwaoJun Watanabe
Mar 29, 2014·Drug Metabolism and Pharmacokinetics·Kazuki SawamotoKen-ichi Miyamoto
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Shigeki TamuraShinji Yamashita
Sep 11, 2013·Medical Hypotheses·Vaidehi GargKanchan Kohli
Dec 17, 2011·Transplantation Proceedings·G CheralaA Al-Uzri
Feb 22, 2012·Chemistry and Physics of Lipids·Anna ElgartAmnon Hoffman
Dec 3, 2014·International Journal of Pharmaceutics·Jef StappaertsPatrick Augustijns

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved